Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis by Sasson, SC, Cheung, VTF, Gupta, T, Zaunders, JJ, Nahar, K, Munier, CM-L, Olsson-Brown, A, Ahlenstiel, G, Palendira, U, Scolyer, RA, Carlino, MS, Long, GV, Menzies, AM, Kelleher, A, Payne, M, Fairfax, B, Middleton, MR, Klenerman, P, Brain, O